The Vanguard Group 13D and 13G filings for Cara Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 5:01 pm Sale | 2023-12-29 | 13G | CARA THERAPEUTICS INC CARA | The Vanguard Group | 73,085 4.830% | -13,074 (-15.17%) | Filing |
| 2023-02-09 11:12 am Purchase | 2022-12-30 | 13G | CARA THERAPEUTICS INC CARA | The Vanguard Group | 86,159 5.770% | 1,916 (+2.27%) | Filing |
| 2022-02-09 3:33 pm Purchase | 2021-12-31 | 13G | CARA THERAPEUTICS INC CARA | The Vanguard Group | 84,243 5.670% | 84,243 (New Position) | Filing |